EcoDrugPlus

Melanocortin 4 Receptor

Ensembl ID : ENSUPAG00010012183
Gene Symbol: MC4R
3 Cross references
121 Possible Orthologues:

Melatonin Receptor 1a

Ensembl ID : ENSUPAG00010006549
Gene Symbol: MTNR1A
3 Cross references
205 Possible Orthologues:

Melatonin Receptor 1b

Ensembl ID : ENSUPAG00010000937
Gene Symbol: MTNR1B
3 Cross references
107 Possible Orthologues:

Membrane Metalloendopeptidase

Ensembl ID : ENSUPAG00010006795
Gene Symbol: MME
1 Cross references
236 Possible Orthologues:

Methionyl Aminopeptidase 2

Ensembl ID : ENSUPAG00010006537
Gene Symbol: METAP2
1 Cross references
214 Possible Orthologues:

Mitogen-Activated Protein Kinase 1

Ensembl ID : ENSUPAG00010013633
Gene Symbol: MAPK1
1 Cross references
213 Possible Orthologues:

Mitogen-Activated Protein Kinase 10

Ensembl ID : ENSUPAG00010010527
Gene Symbol: MAPK10
1 Cross references
147 Possible Orthologues:

Mitogen-Activated Protein Kinase 11

Ensembl ID : ENSUPAG00010005908
Gene Symbol: MAPK11
3 Cross references
200 Possible Orthologues:

Mitogen-Activated Protein Kinase 14

Ensembl ID : ENSUPAG00010015552
Gene Symbol: MAPK14
1 Cross references
281 Possible Orthologues:

Mitogen-Activated Protein Kinase 3

Ensembl ID : ENSUPAG00010009760
Gene Symbol: MAPK3
1 Cross references
198 Possible Orthologues:

Mitogen-Activated Protein Kinase 8

Ensembl ID : ENSUPAG00010007510
Gene Symbol: MAPK8
3 Cross references
294 Possible Orthologues:

Mitogen-Activated Protein Kinase 9

Ensembl ID : ENSUPAG00010013292
Gene Symbol: MAPK9
1 Cross references
219 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).